These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6473980)

  • 1. [Treatment of pulmonary hypertension with vasodilation agents].
    Tschopp JM
    Schweiz Rundsch Med Prax; 1984 Jun; 73(25):789-91. PubMed ID: 6473980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator agents in pulmonary hypertension].
    Farga V
    Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 6. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
    Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G
    J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240
    [No Abstract]   [Full Text] [Related]  

  • 7. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 8. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

  • 12. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of severe pulmonary hypertension during surgery for congenital heart disease.
    Shyamkrishnan KG; Waikar HD; Titus T
    Indian Heart J; 1996; 48(2):159-60. PubMed ID: 8682557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expectations in the vasodilator treatment of secondary pulmonary hypertension].
    Domenighetti G; Perret C
    Schweiz Med Wochenschr; 1984 Nov; 114(46):1642-4. PubMed ID: 6515365
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasodilator agents in the treatment of hypertension of the lesser circulation].
    Zaslavskaia RM
    Klin Med (Mosk); 1969 Nov; 47(11):120-6. PubMed ID: 5380020
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasodilator therapy in pulmonary hypertension].
    Widimský J
    Vnitr Lek; 1986 Oct; 32(10):1021-7. PubMed ID: 3788070
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic evaluation of vasodilator drug therapy in primary pulmonary hypertension.
    Gould L; Chokshi AB; Patel S; Gomes GI
    Am Heart J; 1981 Aug; 102(2):300. PubMed ID: 7258106
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasodilator therapy for pulmonary hypertension.
    Olukotun AY
    N Engl J Med; 1980 May; 302(22):1261-2. PubMed ID: 6154242
    [No Abstract]   [Full Text] [Related]  

  • 20. Epoprostenol for primary pulmonary hypertension.
    Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.